Shaneice Mitchell

BRD4 Profiling Identifies Critical Chronic Lymphocytic Leukemia Oncogenic Circuits and Reveals Sensitivity to PLX51107, a Novel Structurally Distinct BET Inhibitor

Hatice Gülçin Özer, Dalia El‐Gamal, Ben Powell et al. · Cancer Discovery · 2018 · 135 citations · Full text

Next-generation XPO1 inhibitor shows improved efficacy and in vivo tolerability in hematological malignancies

Zachary A. Hing, Ho Yee Joyce Fung, Punithavathi Ranganathan et al. · Leukemia · 2016 · 134 citations · Full text

Hematological Malignancy, Medicine, Malignant Blood Disorder +9

Aberrant activation of TCL1A promotes stem cell expansion in clonal haematopoiesis

Joshua S. Weinstock, Jayakrishnan Gopakumar, Bala Bharathi Burugula et al. · Nature · 2023 · 94 citations · Full text

Stem Cell Expansion, Developmental Biology, Medicine +10

Selective targeting of NAMPT by KPT-9274 in acute myeloid leukemia

Shaneice Mitchell, Karilyn Larkin, Nicole R. Grieselhuber et al. · Blood Advances · 2019 · 62 citations · Full text

Targeting DNA Damage Repair Functions of Two Histone Deacetylases, HDAC8 and SIRT6, Sensitizes Acute Myeloid Leukemia to NAMPT Inhibition

Pu Zhang, Lindsey T. Brinton, Katie Williams et al. · Clinical Cancer Research · 2021 · 32 citations · Full text